Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples